GF Fund Management’s Boston Scientific BSX Stock Holding History

GF Fund Management’s Portfolio BSX Stock Details BSX Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q3	$1.8M	Hold	41,184	–	–	0.02%	155
2026 Q2	$1.76M	Buy	41,184 +435	+1%	+$23.6K	0.02%	162
2026 Q1	$2.56M	Hold	40,749	–	–	0.04%	157
2025 Q4	$3.89M	Sell	40,749 -769	-2%	-$75.4K	0.07%	150
2025 Q3	$4.05M	Buy	41,518 +10,498	+34%	+$1.09M	0.07%	152
2025 Q2	$3.33M	Sell	31,020 -232	-0.7%	-$23.5K	0.07%	164
2025 Q1	$3.15M	Hold	31,252	–	–	0.07%	159
2024 Q4	$2.79M	Buy	+31,252	New	+$2.75M	0.06%	163

Other funds holding BSX

State Street Boston, Massachusetts $3.44T AUM 36.12% 1-Year Est. Return

Primecap Management Pasadena, California $161B AUM 86.05% 1-Year Est. Return

Massachusetts Financial Services Boston, Massachusetts $296B AUM 23.14% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $2.32T AUM 44.66% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.92T AUM 36.1% 1-Year Est. Return

Capital World Investors Los Angeles, California $824B AUM 37.44% 1-Year Est. Return

Franklin Resources San Mateo, California $474B AUM 32.39% 1-Year Est. Return

JP Morgan Chase New York $1.84T AUM 33.86% 1-Year Est. Return

Capital Research Global Investors Los Angeles, California $704B AUM 26.74% 1-Year Est. Return

Invesco Atlanta, Georgia $1.27T AUM 50.62% 1-Year Est. Return

GF Fund Management's BSX Position: Q3 2026 in Review

GF Fund Management held its Boston Scientific (BSX) position steady in Q3 2026 at 41,184 shares worth $1.8M. The position accounts for 0.02% of the portfolio, ranked #155.

GF Fund Management first reported a position in BSX in Q4 2024 and has held it in 8 quarters since. The position peaked at $4.05M in Q3 2025. 1,154 funds tracked by Wall St. Rank hold BSX as of Q3 2026.

GF Fund Management held 41,184 shares of Boston Scientific worth $1.8M as of Q3 2026.
GF Fund Management left its Boston Scientific share count unchanged in Q3 2026.
Boston Scientific made up 0.02% of GF Fund Management's portfolio in Q3 2026, its #155 holding.
GF Fund Management first reported a position in Boston Scientific in Q4 2024 and has held it in 8 quarters since.
GF Fund Management's Boston Scientific position peaked at $4.05M in Q3 2025.
1,154 funds tracked by Wall St. Rank held Boston Scientific as of Q3 2026.

Based on GF Fund Management's 13F filing for Q3 2026, filed 26 Oct 2026.